IOSP (Innospec) Cyclically Adjusted PB Ratio: 1.74 (As of Jul. 13, 2026) — 44% Below Median


IOSP Innospec Inc IOSP
76 GF Score
Price $81.72
GF Value $94.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Innospec Cyclically Adjusted PB Ratio?

Innospec IOSP +0.12% 76 Cyclically Adjusted PB Ratio is 1.74 as of Jul. 13, 2026, which is 44% below its 10-year median of 3.11. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,284 Chemicals companies, Innospec ranks worse than 50.62% on this metric.

As of today (2026-07-13), Innospec's current share price is $81.72. Innospec's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $47.00. Innospec's Cyclically Adjusted PB Ratio for today is 1.74.

The historical rank and industry rank for Innospec's Cyclically Adjusted PB Ratio or its related term are showing as below:

IOSP' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.44   Med: 3.11   Max: 4.57
Current: 1.74

During the past years, Innospec's highest Cyclically Adjusted PB Ratio was 4.57. The lowest was 1.44. And the median was 3.11.

IOSP's Cyclically Adjusted PB Ratio is ranked worse than
50.62% of 1284 companies
in the Chemicals industry
Industry Median: 1.7 vs IOSP: 1.74

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Innospec's adjusted book value per share data for the three months ended in Mar. 2026 was $54.414. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $47.00 for the trailing ten years ended in Mar. 2026.

Shiller PE for Stocks: The True Measure of Stock Valuation


Innospec  (NAS:IOSP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Innospec Cyclically Adjusted PB Ratio Related Terms


Innospec Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Innospec's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec Cyclically Adjusted PB Ratio Chart

Innospec Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.91 2.91 3.16 2.59 1.68

Innospec Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.17 1.89 1.70 1.68 1.55

IOSP vs MTX, ODC, NGVT: Cyclically Adjusted PB Ratio Comparison

For the Specialty Chemicals subindustry, Innospec's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innospec Cyclically Adjusted PB Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innospec's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Innospec's Cyclically Adjusted PB Ratio falls into.


IOSP
76GF Score
Innospec Inc IOSP
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innospec Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Innospec's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=81.72/47.00
=1.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Innospec's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=54.414/330.2130*330.2130
=54.414

Current CPI (Mar. 2026) = 330.2130.

Innospec Quarterly Data

Book Value per Share CPI Adj_Book
201606 26.662 241.018 36.529
201609 27.183 241.428 37.180
201612 27.149 241.432 37.132
201703 28.022 243.801 37.954
201706 29.167 244.955 39.319
201709 30.968 246.819 41.431
201712 32.604 246.524 43.672
201803 33.783 249.554 44.702
201806 33.556 251.989 43.973
201809 34.388 252.439 44.983
201812 33.764 251.233 44.378
201903 34.657 254.202 45.020
201906 35.232 256.143 45.420
201909 35.998 256.759 46.296
201912 37.479 256.974 48.161
202003 38.427 258.115 49.161
202006 36.599 257.797 46.880
202009 37.653 260.280 47.770
202012 38.396 260.474 48.676
202103 38.955 264.877 48.564
202106 39.510 271.696 48.020
202109 40.272 274.310 48.479
202112 41.673 278.802 49.357
202203 43.047 287.504 49.442
202206 43.067 296.311 47.994
202209 43.975 296.808 48.924
202212 41.912 296.797 46.631
202303 43.355 301.836 47.431
202306 43.923 305.109 47.537
202309 45.257 307.789 48.554
202312 46.128 306.746 49.657
202403 47.471 312.332 50.189
202406 47.817 314.175 50.258
202409 49.852 315.301 52.210
202412 48.526 315.605 50.772
202503 50.452 319.799 52.095
202506 52.028 322.561 53.262
202509 52.345 324.800 53.217
202512 53.519 324.054 54.536
202603 54.414 330.213 54.414

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PB Ratio of 1.74 mean?
Innospec (IOSP) has a Cyclically Adjusted PB Ratio of 1.74 as of Jul. 13, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Innospec and its competitors. This is 44% below median its historical median of 3.11. Over the past decade, Innospec's Cyclically Adjusted PB Ratio has ranged from 1.44 to 4.57. According to the industry distribution chart, Innospec ranks #650 out of 1284 companies in the Chemicals industry, placing it in the top 50.6%.
Is Innospec's Cyclically Adjusted PB Ratio too high?
Innospec's current Cyclically Adjusted PB Ratio of 1.74 is 44% below median its 10-year median of 3.11. Over the past 10 years, this metric has ranged from a low of 1.44 to a high of 4.57. The Chemicals industry median Cyclically Adjusted PB Ratio is 1.70. Innospec's value of 1.74 is 2.4% above this industry median. Based on the distribution chart, Innospec ranks #650 out of 1284 companies in the Chemicals industry, which is below the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's Cyclically Adjusted PB Ratio compare to MTX and ODC?
According to the Chemicals industry distribution chart, Innospec ranks #650 out of 1284 companies for Cyclically Adjusted PB Ratio. This places Innospec in the lower half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.70. Innospec's value of 1.74 is 2.4% above this benchmark. Historically, Innospec's own Cyclically Adjusted PB Ratio has ranged from 1.44 to 4.57 over the past decade. While the company's 10-year median is 3.11 vs. the industry median of 1.70, Innospec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Chemicals company?
The median Cyclically Adjusted PB Ratio among Chemicals companies is 1.70, based on 1,284 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innospec's current Cyclically Adjusted PB Ratio of 1.74 is 2.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Innospec and its competitors. For the Chemicals industry, the median Cyclically Adjusted PB Ratio is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innospec's current Cyclically Adjusted PB Ratio is 1.74, which is 44% below median its own 10-year median of 3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.91, compared to a current price of $81.72 — trading 13.9% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 1.74, which is 44% below median its 10-year median of 3.11 and 2.4% above the Chemicals industry median of 1.70. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Innospec (IOSP), the current Cyclically Adjusted PB Ratio is 1.74 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Innospec (IOSP) Overvalued in 2026?

Based on GuruFocus' analysis, Innospec stock appears to be undervalued. The current stock price of $81.72 is trading 13.9% below its estimated GF Value™ of $94.91. GuruFocus considers Innospec to be Modestly Undervalued.

Key valuation signals for IOSP:

  • Cyclically Adjusted PB Ratio: 1.74 (44% below median its 10-year median of 3.11)
  • GF Value™: $94.91 vs. price of $81.72 (13.9% below fair value)
  • GF Score™: 76/100 with 3 warning signs
  • Industry Position: 2.4% above the Chemicals median (#650 of 1284)

No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innospec Business Description

Other Exchanges 0JAX:UKOCT:Germany
Address 8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score

Get the complete analysis for IOSP

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.72
Price
$94.91
GF Value